• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一系列三苯丁-1-烯中的雌激素和抗雌激素作用:体外催乳素合成的调节

Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.

作者信息

Jordan V C, Koch R, Mittal S, Schneider M R

出版信息

Br J Pharmacol. 1986 Jan;87(1):217-23. doi: 10.1111/j.1476-5381.1986.tb10174.x.

DOI:10.1111/j.1476-5381.1986.tb10174.x
PMID:3955300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1916918/
Abstract

The oestrogenic and antioestrogenic activities of a series of substituted derivatives of 1,1,2 triphenylbut-1-ene have been determined using primary cultures of rat pituitary gland cells to monitor prolactin synthesis in vitro. The relative binding affinity of the agonists for the oestrogen receptor was consistent with their oestrogenic potency. Bis para substitution at C1 of 1,1,2 triphenylbut-1-ene with either phenolic or acetoxy groups produced partial agonists. The antioestrogenic properties were reversible by the incubation of cells with increasing concentrations of oestradiol. The results lend support to a hypothetical single binding site model of oestrogen action, based upon an adaptation of Belleau's macromolecular perturbation theory.

摘要

利用大鼠垂体腺细胞原代培养物来监测体外催乳素的合成,已测定了一系列1,1,2-三苯基丁-1-烯取代衍生物的雌激素活性和抗雌激素活性。这些激动剂对雌激素受体的相对结合亲和力与它们的雌激素效力一致。在1,1,2-三苯基丁-1-烯的C1位进行双对位取代,用酚基或乙酰氧基取代会产生部分激动剂。通过用浓度递增的雌二醇孵育细胞,抗雌激素特性是可逆的。基于对贝洛大分子扰动理论的改编,这些结果支持了雌激素作用的假设单结合位点模型。

相似文献

1
Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.一系列三苯丁-1-烯中的雌激素和抗雌激素作用:体外催乳素合成的调节
Br J Pharmacol. 1986 Jan;87(1):217-23. doi: 10.1111/j.1476-5381.1986.tb10174.x.
2
Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro.非甾体类抗雌激素体外药理活性的结构要求
Mol Pharmacol. 1984 Sep;26(2):272-8.
3
Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure.雌激素刺激下的体外催乳素合成。基于结构的激动剂、部分激动剂和拮抗剂作用分类。
Mol Pharmacol. 1984 Sep;26(2):279-85.
4
Acetoxy substituted 1,1,2-triphenylbut-1-enes: estrogenic, antiestrogenic and mammary tumor inhibiting activity.乙酰氧基取代的1,1,2-三苯基丁-1-烯:雌激素活性、抗雌激素活性及抑制乳腺肿瘤活性
J Cancer Res Clin Oncol. 1986;112(2):119-24. doi: 10.1007/BF00404393.
5
Catechol estrogens of the 1,1,2-triphenylbut-1-ene type: relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities.1,1,2-三苯基丁-1-烯型儿茶酚雌激素:结构、雌二醇受体亲和力、雌激素和抗雌激素特性以及乳腺肿瘤抑制活性之间的关系
J Med Chem. 1986 Aug;29(8):1355-62. doi: 10.1021/jm00158a006.
6
Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.非甾体抗雌激素代谢活化的证据:构效关系研究
Br J Pharmacol. 1980;71(1):83-91. doi: 10.1111/j.1476-5381.1980.tb10912.x.
7
[The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen].
Bull Cancer. 1994 Jan;81(1):29-37.
8
An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro.一种用于描述抗雌激素在体外对催乳素合成调节作用的雌激素受体模型。
J Biol Chem. 1983 Apr 25;258(8):4741-5.
9
1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties.1,1,2-三苯基丁-1-烯:结构、雌二醇受体亲和力与乳腺肿瘤抑制特性之间的关系
J Med Chem. 1982 Sep;25(9):1070-7. doi: 10.1021/jm00351a013.
10
Laboratory models of breast cancer to aid the elucidation of antiestrogen action.用于辅助阐明抗雌激素作用的乳腺癌实验室模型。
J Lab Clin Med. 1987 Mar;109(3):267-77.

引用本文的文献

1
Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures.雌激素治疗和预防乳腺癌:卡氏 2 个讲座的故事。
Cancer J. 2022;28(3):163-168. doi: 10.1097/PPO.0000000000000600.
2
Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer.雌激素受体复合物触发或延迟长期雌激素剥夺的乳腺癌中雌激素诱导的细胞凋亡。
Front Endocrinol (Lausanne). 2022 Mar 10;13:869562. doi: 10.3389/fendo.2022.869562. eCollection 2022.
3
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.将科学偶然发现转化为乳腺癌研究和治疗的发现:一个博士生和一个 50 年漫游他莫昔芬团队的故事。
Breast Cancer Res Treat. 2021 Nov;190(1):19-38. doi: 10.1007/s10549-021-06356-8. Epub 2021 Aug 16.
4
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer.临床相关雌激素雌三醇和雌激素模拟物 BMI-135 的药理学和分子机制及其在治疗内分泌抵抗型乳腺癌中的应用。
Mol Pharmacol. 2020 Oct;98(4):364-381. doi: 10.1124/molpharm.120.000054. Epub 2020 Aug 12.
5
The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture.SERM 传奇,无中生有:美国癌症协会/SSO 基础科学讲座。
Ann Surg Oncol. 2019 Jul;26(7):1981-1990. doi: 10.1245/s10434-019-07291-1. Epub 2019 Mar 25.
6
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.雌激素剥夺治疗后靶向雌激素受体的分子、细胞及临床后果。
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):245-63. doi: 10.1016/j.mce.2015.06.004. Epub 2015 Jun 5.
7
Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.在乳腺癌转移灶中发现的雌激素受体突变与选择性雌激素受体调节剂的分子药理学相结合。
J Natl Cancer Inst. 2015 Apr 2;107(6):djv075. doi: 10.1093/jnci/djv075. Print 2015 Jun.
8
The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.雌激素诱导凋亡的新生物学应用于治疗和预防乳腺癌。
Endocr Relat Cancer. 2015 Feb;22(1):R1-31. doi: 10.1530/ERC-14-0448. Epub 2014 Oct 22.
9
Differences in the rate of oestrogen-induced apoptosis in breast cancer by oestradiol and the triphenylethylene bisphenol.雌二醇和三苯乙烯双酚在雌激素诱导乳腺癌细胞凋亡速率上的差异。
Br J Pharmacol. 2014 Sep;171(17):4062-72. doi: 10.1111/bph.12762.
10
Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cells.Endoxifen 和 4-羟基他莫昔芬的抗雌激素侧链的长度和定位对雌激素受体阳性癌细胞基因激活和生长的影响。
J Med Chem. 2014 Jun 12;57(11):4569-83. doi: 10.1021/jm500569h. Epub 2014 May 22.

本文引用的文献

1
A MOLECULAR THEORY OF DRUG ACTION BASED ON INDUCED CONFORMATIONAL PERTURBATIONS OF RECEPTORS.
J Med Chem. 1964 Nov;7:776-84. doi: 10.1021/jm00336a022.
2
Gonadotrophin inhibiting and anti-fecundity effects of chloramiphene.氯米芬对促性腺激素的抑制作用及抗生育力效应。
Proc Soc Exp Biol Med. 1960 Oct;105:197-201. doi: 10.3181/00379727-105-26054.
3
A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol.一种非甾体雌激素拮抗剂1-(对-2-二乙氨基乙氧基苯基)-1-苯基-2-对甲氧基苯基乙醇。
Endocrinology. 1958 Sep;63(3):295-318. doi: 10.1210/endo-63-3-295.
4
Prolactin synthesis in primary cultures of pituitary cells: regulation by estradiol.垂体细胞原代培养物中催乳素的合成:雌二醇的调节作用
Mol Cell Endocrinol. 1982 Mar;25(3):277-94. doi: 10.1016/0303-7207(82)90084-3.
5
An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro.一种用于描述抗雌激素在体外对催乳素合成调节作用的雌激素受体模型。
J Biol Chem. 1983 Apr 25;258(8):4741-5.
6
Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro.体外抗雌激素对雌二醇刺激的催乳素合成的直接和可逆抑制作用。
J Biol Chem. 1983 Apr 25;258(8):4734-40.
7
1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties.1,1,2-三苯基丁-1-烯:结构、雌二醇受体亲和力与乳腺肿瘤抑制特性之间的关系
J Med Chem. 1982 Sep;25(9):1070-7. doi: 10.1021/jm00351a013.
8
Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.用人雌激素受体抗体鉴定的人乳腺肿瘤中雌激素与抗雌激素 - 雌激素受体复合物之间的差异。
Cancer Res. 1984 Mar;44(3):1012-8.
9
Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure.雌激素刺激下的体外催乳素合成。基于结构的激动剂、部分激动剂和拮抗剂作用分类。
Mol Pharmacol. 1984 Sep;26(2):279-85.
10
Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro.非甾体类抗雌激素体外药理活性的结构要求
Mol Pharmacol. 1984 Sep;26(2):272-8.